Publications

Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR).

Jackson TL. et al, (2026), BMJ, 393

Patellar resurfacing in total knee replacement: 20-year clinical and economic results of a large multicentre, randomised controlled trial in the UK.

Murray DW. et al, (2026), Lancet

Supporting women with adherence to adjuvant endocrine therapy (SWEET): feasibility study of the HT&Me intervention.

McGeagh L. et al, (2026), Eur J Oncol Nurs, 80

EQ-5D vision bolt-on in macular degeneration: Associations with visual measures and effect on utility differences and cost-effectiveness of stereotactic radiotherapy

Zhu X. et al, (2026), Health and Quality of Life Outcomes

Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer.

McGeagh L. et al, (2025), Trials, 26

HERC database of mapping studies, Version 10.0

DAKIN H. et al, (2025)

Stereotactic radiotherapy for nAMD: areas for improvement - Authors' reply.

Jackson TL. et al, (2025), Lancet, 406, 26 - 27

Using QALYs as an Outcome for Assessing Global Prediction Accuracy in Diabetes Simulation Models.

Dakin HA. et al, (2025), Med Decis Making, 45, 45 - 59

Q-SQUARED AS A MAPPING MODEL PERFORMANCE METRIC IN GASTROINTESTINAL DISEASE

Mallon K. et al, (2025), VALUE IN HEALTH, 28

THE HERC DATABASE OF MAPPING STUDIES: A 2025 UPDATE OF A LIVE SYSTEMATIC REVIEW OF STUDIES PREDICTING EQ-5D FROM OTHER PATIENT-REPORTED OUTCOME MEASURES

Mallon K. et al, (2025), VALUE IN HEALTH, 28

Supporting Women With Adherence to Endocrine Therapy: HT&Me Intervention in Early Breast Cancer

Brett J. et al, (2025), ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 21

How are maternal and fetal outcomes incorporated when measuring benefits of interventions in pregnancy? Findings from a systematic review of cost-utility analyses.

Abel L. et al, (2024), Health Qual Life Outcomes, 22

Estimating Risk Factor Time Paths Among People with Type 2 Diabetes and QALY Gains from Risk Factor Management.

Gao N. et al, (2024), Pharmacoeconomics, 42, 1017 - 1028

Using orthopaedic health care resources efficiently: A cost analysis of day surgery for unicompartmental knee replacement.

Hlatshwako TG. et al, (2024), Knee, 49, 147 - 157

Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial.

Jackson TL. et al, (2024), Lancet, 404, 44 - 54

Search results (126)